Mimedx Group Inc (NASDAQ: MDXG) on Friday, soared 4.86% from the previous trading day, before settling in for the closing price of $6.58. Within the past 52 weeks, MDXG’s price has moved between $5.57 and $9.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -1.19% over the last five years. The company achieved an average annual earnings per share of -27.03%. With a float of $114.78 million, this company’s outstanding shares have now reached $146.23 million.
The firm has a total of 895 workers. Let’s measure their productivity. In terms of profitability, gross margin is 83.3%, operating margin of 21.86%, and the pretax margin is 20.29%.
Mimedx Group Inc (MDXG) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mimedx Group Inc is 21.82%, while institutional ownership is 45.67%. The most recent insider transaction that took place on Mar 13 ’24, was worth 162,029. In this transaction General Counsel and CAO of this company sold 20,381 shares at a rate of $7.95, taking the stock ownership to the 479,959 shares. Before that another transaction happened on Feb 16 ’24, when Company’s Chief Operating Officer sold 15,493 for $8.07, making the entire transaction worth $125,075. This insider now owns 416,321 shares in total.
Mimedx Group Inc (MDXG) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -27.03% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Mimedx Group Inc (MDXG) is currently performing well based on its current performance indicators. A quick ratio of 3.22 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.98. Likewise, its price to free cash flow for the trailing twelve months is 21.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.59, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
Analysing the last 5-days average volume posted by the [Mimedx Group Inc, MDXG], we can find that recorded value of 0.56 million was lower than the volume posted last year of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 90.27%. Additionally, its Average True Range was 0.26.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 48.26%, which indicates a significant decrease from 96.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.74% in the past 14 days, which was lower than the 47.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.86, while its 200-day Moving Average is $7.45. Now, the first resistance to watch is $7.02. This is followed by the second major resistance level at $7.13. The third major resistance level sits at $7.34. If the price goes on to break the first support level at $6.70, it is likely to go to the next support level at $6.49. Should the price break the second support level, the third support level stands at $6.38.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
Market capitalization of the company is 1.01 billion based on 147,604K outstanding shares. Right now, sales total 321,480 K and income totals 58,230 K. The company made 87,210 K in profit during its latest quarter, and 17,630 K in sales during its previous quarter.
